Insider · CIK 0001746298
Richard Scott Struthers
ceopresidentofficerdirector
Files at CRNX (Crinetics Pharmaceuticals, Inc.). First filing Dec 4, 2024, latest Mar 21, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $1.2M sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 39Weak | Crinetics Pharmaceuticals, Inc. | $593k 17,338 shares | -5% | - | |
| 32Weak | Crinetics Pharmaceuticals, Inc. | $576k 10,000 shares | -9% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Common Stock | -248,043 | $85.00 | $21M | 176,663 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Common Stockindirect: By Spouse | -1,000 | $85.00 | $85k | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Common Stockindirect: By Family Trust 1 | -136,805 | $85.00 | $12M | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Common Stockindirect: By Family Trust 2 | -106,000 | $85.00 | $9.0M | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Common Stockindirect: By Family Trust 3 | -110,000 | $85.00 | $9.3M | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Common Stockindirect: By Family Trust 4 | -100,000 | $85.00 | $8.5M | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Common Stockindirect: By Family Trust 5 | -111,100 | $85.00 | $9.4M | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Common Stockindirect: By Family Trust 6 | -111,100 | $85.00 | $9.4M | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Common Stockindirect: By Family Trust 7 | -111,100 | $85.00 | $9.4M | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Common Stockindirect: By Family Trust 8 | -111,100 | $85.00 | $9.4M | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Common Stockindirect: By Charitable Trust | -80,000 | $85.00 | $6.8M | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Common Stock | -176,663 | $85.00 | $15M | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -172,281 | $59.81 | $10M | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -195,578 | $62.39 | $12M | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -259,058 | $69.71 | $18M | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -244,205 | $64.98 | $16M | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -287,700 | $65.36 | $19M | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -240,000 | $41.49 | $10.0M | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -313,000 | $48.14 | $15M | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -228,000 | $41.21 | $9.4M | 0 | 41 d ago |
| May 14, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | GGift Common Stock | -90,400 | $0.00 | $0 | 320,017 | May 16, 2025 |
| May 14, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | GGift Common Stockindirect: By Family Trust 1 | +90,400 | $0.00 | $0 | 661,205 | May 16, 2025 |
| Apr 2, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | MOption exercise Common Stock | +81,270 | $1.91 | $155k | 410,417 | Apr 4, 2025 |
| Apr 2, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -81,270 | $0.00 | $0 | 0 | Apr 4, 2025 |
| Mar 19, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -16,463 | $34.17 | $563k | 330,022 | Mar 21, 2025 |
| Mar 19, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -875 | $34.83 | $30k | 329,147 | Mar 21, 2025 |
| Feb 20, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | AGrant or award Common Stock | +89,000 | $0.00 | $0 | 346,485 | Feb 24, 2025 |
| Feb 20, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +313,000 | $0.00 | $0 | 313,000 | Feb 24, 2025 |
| Dec 2, 2024 | CRNX Crinetics Pharmaceuticals, Inc. | SOpen-market sale Common Stockindirect: By Family Trust 410b5-1 | -10,000 | $57.57 | $576k | 100,000 | Dec 4, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.